4 ms·
But as forrestthewoods pointed out, if the improvements in the new version are so marginal, then you'd think there would be a booming market for the old version
by roadnottaken 11y ago
But as forrestthewoods pointed out, if the improvements in the new version are so marginal, then you'd think there would be a booming market for the old version if it was cheaper (generic). So what's stopping the generic manufacturers from cranking out the old versions? Seems like there would be lots of money to be made, unless patients (the market) actually did value the incremental improvements and would likely chose not to purchase the original formulation.
- CWuestefeld 11y agoWell, in my example, it seems like the manufacturer hasn't just moved onto an abstractly nicer formulation, but in the process they've left some FUD that the previous version might be problematic (for some subgroup).
- akavlie 11y agoI'm sure most people outside that subgroup would jump at the chance to get a cheaper substitute. Asacol HD is $600 - $700 for 90 pills: http://www.goodrx.com/asacol-hd http://www.goodrx.com/asacol-hd
- CWuestefeld 11y agoYou should see the other stuff I take, Entyvio[1], at around $25K/dose (which is every other month). I don't know why they list it for various pharmacies, since you can't buy it - it has to be administered by an infusion center. I'm the reason that healthcare insurance is so expensive. [1] http://www.goodrx.com/entyvio http://www.goodrx.com/entyvio
- deleted 11y ago[deleted]